Tamoxifen has been used for treatment of ERα-positive breast tumors that requires estrogen to grow due to the antagonistic effect of hydroxytamoxifen (an active metabolite of tamoxifen) to the breast ER (Ring and Dowsett 2004). Here, ESR1 is linked to breast neoplasm.